2 Millionen Bücher heute bestellen und morgen im Press & Books oder k kiosk abholen.
Kontakt Filiale finden
Merkliste
Die Merkliste ist leer.
Der Warenkorb ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

Emerging Trends in Information and Communication Security

International Conference, ETRICS 2006, Freiburg, Germany, June 6-9, 2006. Proceedings
BuchKartoniert, Paperback
Verkaufsrang522390inEnglish Non Fiction A-Z
CHF135.00

Beschreibung

This book constitutes the refereed proceedings of the International Conference on Emerging Trends in Information and Communication Security, ETRICS 2006, held in Freiburg, Germany, in June 2006. The book presents 36 revised full papers, organized in topical sections on multilateral security; security in service-oriented computing, secure mobile applications; enterprise privacy; privacy, identity, and anonymity; security engineering; security policies; security protocols; intrusion detection; and cryptographic security.
Weitere Beschreibungen

Details

ISBN/GTIN978-3-540-34640-1
ProduktartBuch
EinbandKartoniert, Paperback
Erscheinungsdatum06.06.2006
ReiheLecture Notes in Computer Science
Reihen-Nr.3995
Seiten532 Seiten
SpracheEnglisch
Artikel-Nr.23191860
WarengruppeEnglish Non Fiction
DetailwarengruppeEnglish Non Fiction A-Z
Weitere Details

Reihe

Autor

Günter Müller is senior scientist for Biochemistry at Aventis Pharma Germany, Frankfurt am Main, and honorary lecturer for genetics at the University of Munich. He was born in Peissenberg (Germany) and studied anthropology, zoology, genetics and biochemistry at the Ludwig-Maximilians-University in Munich, finishing his PhD thesis under the supervision of R. Zimmermann in 1987. After post-doctoral fellowships at the universities of Ulm and Heidelberg, he joined the pharmaceutical industry in 1990 and received his habilitation at the University of Munich in 1996. He is interested in molecular mechanisms in both lower eukaryotes and mammalian cells, and their use as drug targets for metabolic disorders.